Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

20

Revenue 2017

Triumeq

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Triumeq was produced by GlaxoSmithKline.

Gilead’s triple HIV drug approval prompts GSK lawsuit

Gilead’s triple HIV drug approval prompts GSK lawsuit which was first approved in the US in 2013 and is a key component of ViiV’s latest HIV product launches including three-drug combo Triumeq and recently-approved Juluca. ... forecasts. Tivicay and Triumeq posted strong growth to reach £1.4bn and

GSK’s ViiV gets US okay for two-drug HIV regimen

GSK’s ViiV gets US okay for two-drug HIV regimen ViiV has said Juluca will be priced at about $31, 000-a-year, comparable to its three-drug HIV regimen Triumeq (abacavir, lamivudine and dolutegravir), a $1.7bn product that is

CDC backs GSK’s Shingrix over Merck & Co’s Zostavax

CDC backs GSK’s Shingrix over Merck & Co’s Zostavax Once again HIV therapies Tivicay (dolutegravir) and Triumeq (dolutegravir, abacavir and lamivudine) - up 45% to £1.47bn - led the advance amongst GSK’s prescription pharma business, with support from new asthma

ViiV files two-drug HIV maintenance regimen

ViiV files two-drug HIV maintenance regimen s fast-growing Triumeq (dolutegravir, abacavir and lamivudine) but not - as it had hoped - a superior profile. ... With Triumeq likely to feel the pinch ViiV will be hoping its emphasis on two-drug regimens could keep it on a competitive footing.

Gilead plans fightback against HIV arch-rival ViiV

Gilead plans fightback against HIV arch-rival ViiV Descovy sees phase III success after the TAF-based drug proves non-inferior to Triumeq. ... Triumeq, which contains rival integrase Tivicay (dolutegravir) as well as abacavir and lamivudine.

[ Previous 5 results ] 1 2 3 4 5 6 7 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...
MIT reveals new pill to deliver insulin
A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...
Fearless Girl cover
25 Women Leaders in UK Healthcare
Women trailblazers helping to shape the future of healthcare (Part 1)...

Infographics